USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CCS Inc.

USPTO PatentsView assignee record - 17 granted patents across 16 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, CCS ranks #16,670 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 16 technology areas.

#16,670
of 49,997 US assignees by volume
Top 22%
by Innovation Score (45.7/100)
8.2
avg claims per patent
-45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16670 · Foreign Corporation #16,670 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 17 grants
  • MID-PACK #16,670/49,997
  • PHOTO-FINISH Cambia Health…
  • CPC-FOCUS G01N · 16 areas
  • INNOV-PAR 45.7/100
  • CLAIMS-PAR 8.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -45% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cambia Health Solutions, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CCS’s 45.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around CCS

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows CCS's Innovation Score is 45.7/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for CCS?

Each dot is one of CCS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CCS’s own 8.2 claims/patent is at or below the 11.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

CCS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 16.916.91717.1 0510152025 Granted patents (volume) Avg claims / patent Cambia Health Solutions, Inc. - 17, 16.65Cambia Health Sol…Cane-line A/S - 17, 1Cane-line A/SCarter-hoffmann LLC - 17, 11.82Carter-hoffmannCatheter Precision, Inc. - 17, 11.53Catheter PrecisionCellcontrol, Inc. - 17, 17.41CellcontrolCellmax Technologies AB - 17, 20Cellmax ABCG Technology Development, LLC - 17, 19.76CG Technology Dev…Chengdu Qianniucao Information Technology Co., Ltd. - 17, 9Chengdu Qianniuca…CCS Inc. - 17, 8.24CCS
CCS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CCS's grants concentrate

CCS Inc. is a focused PatentsView assignee: 16 CPC subclasses with 47.1% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2019. By volume, CCS sits between Cambia Health Solutions, Inc. and Chengdu Qianniucao Information Technology Co., Ltd..

CCS's three-year grant acceleration

CCS Inc. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CCS's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CCS holds 17 patents at rank #16,666, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CCS

By rank, the assignees closest to #16,666 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in CCS's primary technology class.

CCS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201720182019202020222023 2
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
CCS Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 11.8%
2016 2 11.8%
2017 3 17.6%
2018 3 17.6%
2019 1 5.9%
2020 1 5.9%
2022 3 17.6%
2023 2 11.8%

Which technologies does CCS Inc. patent most?

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CCS Inc.'s patent record in context - here's where to go next.

  • CCS Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 47.1% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #16,670 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CCS Inc. against Cambia Health Solutions, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.